Journal of Clinical Oncology , 0732-183X

Journal

1 - 20 out of 120Page size: 20

Publications

  1. 2020
  2. E-pub ahead of print

    Augmented reduced-intensity regimen does not improve postallogeneic transplant outcomes in acute myeloid leukemia

    Charles Craddock, Aimee Jackson, Justin Loke, Ram Malladi, Keith Wheatley & 7 others, , Naeem Khan & Sylvie Freeman, 29 Dec 2020, (E-pub ahead of print) In: Journal of Clinical Oncology . 12 p., JCO2002308.

    Research output: Contribution to journal › Article › peer-review

  3. E-pub ahead of print

    Defining the Optimal Total Number of Chemotherapy Courses in Younger Patients With Acute Myeloid Leukemia: A Comparison of Three Versus Four Courses

    Sylvie Freeman, 23 Dec 2020, (E-pub ahead of print) In: Journal of Clinical Oncology . p. JCO2001170

    Research output: Contribution to journal › Article › peer-review

  4. E-pub ahead of print

    Elective cancer surgery in COVID-19–free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study

    Aneel Bhangu, 6 Oct 2020, (E-pub ahead of print) In: Journal of Clinical Oncology . 14 p., JCO2001933.

    Research output: Contribution to journal › Article › peer-review

  5. Published

    De-escalation after DE-ESCALATE and RTOG 1016: a head and neck cancer InterGroup framework for future de-escalation studies

    Hisham Mehanna, 1 Aug 2020, In: Journal of Clinical Oncology . 38, 22, p. 2552-2557 7 p.

    Research output: Contribution to journal › Article › peer-review

  6. E-pub ahead of print

    Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL Trials

    Daniel Rea, 24 Jul 2020, (E-pub ahead of print) In: Journal of Clinical Oncology . p. JCO1902427

    Research output: Contribution to journal › Article › peer-review

  7. Published

    Less is not necessarily more: toward a rational selection of the conditioning regimen in acute myeloid leukemia

    Sylvie Freeman, 20 Apr 2020, In: Journal of Clinical Oncology . 38, 12, p. 1249-1251 3 p.

    Research output: Contribution to journal › Editorial

  8. Published

    ARISTOTLE: A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation as preoperative treatment for MRI-defined locally advanced rectal cancer (LARC).

    Simon Bach, 2020, In: Journal of Clinical Oncology . p. 4101-410 9 p.

    Research output: Contribution to journal › Article › peer-review

  9. 2019
  10. Published

    Ibrutinib plus venetoclax in relapsed/refractory chronic lymphocytic leukemia: the CLARITY study

    Kristian Brock, Sam Munoz Vicente, Becky Boucher, 20 Oct 2019, In: Journal of Clinical Oncology . 37, 30, p. 2722-2729 8 p.

    Research output: Contribution to journal › Article › peer-review

  11. Published

    Trans-aTTom: Breast Cancer Index for prediction of endocrine benefit and late distant recurrence (DR) in patients with HR+ breast cancer treated in the adjuvant tamoxifen—To offer more? (aTTom) trial.

    Ikhlaaq Ahmed, Sarah Pirrie & Daniel Rea, 20 May 2019, In: Journal of Clinical Oncology. 37, 15_suppl, p. 505 1 p.

    Research output: Contribution to journal › Abstract › peer-review

  12. Published

    Combination Lenalidomide and Azacitidine: A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia

    Charles Craddock, Daniel Slade, Carmela De Santo, Rachel Hoare, Kristian Brock & Christina Yap, 1 Mar 2019, In: Journal of Clinical Oncology . 37, 7, p. 580-588 9 p., JCO1800889.

    Research output: Contribution to journal › Article › peer-review

  13. Published

    High-dose chemotherapy compared with standard chemotherapy and lung radiation in ewing sarcoma with pulmonary metastases: Results of the european ewing tumour working initiative of national groups, 99 trial and ewing 2008

    & 22 others, , Keith Wheatley, 1 Jan 2019, In: Journal of Clinical Oncology. 37, 34, p. 3192-3202 11 p.

    Research output: Contribution to journal › Article › peer-review

  14. 2018
  15. E-pub ahead of print

    High-dose chemotherapy and blood autologous stem-cell rescue compared with standard chemotherapy in localized high-risk Ewing sarcoma: results of Euro-E.W.I.N.G.99 and Ewing-2008

    6 Sep 2018, (E-pub ahead of print) In: Journal of Clinical Oncology . 16 p.

    Research output: Contribution to journal › Article › peer-review

  16. E-pub ahead of print

    Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features

    Keith Wheatley, 28 Aug 2018, (E-pub ahead of print) In: Journal of Clinical Oncology .

    Research output: Contribution to journal › Article › peer-review

  17. E-pub ahead of print

    Risk, risk factors and surveillance of subsequent malignant neoplasms in childhood cancer survivors: a review

    Raoul Reulen, 6 Jun 2018, (E-pub ahead of print) In: Journal of Clinical Oncology . 36, 9 p.

    Research output: Contribution to journal › Article › peer-review

  18. E-pub ahead of print

    Development and validation of a combined metabolic and immune prognostic classifier for head and neck cancer

    Jill Brooks, Lucinda Archer, Rachel Spruce, Nikos Batis, Jennifer Bryant, Andrew Beggs, Daniel Tennant, Gary Middleton, Jean-Baptiste Cazier, Benjamin Willcox, 1 Jun 2018, (E-pub ahead of print) In: Journal of Clinical Oncology. 36, 15 Suppl, p. 6049-6049

    Research output: Contribution to journal › Abstract › peer-review

  19. Published

    Measurable residual disease at induction redefines partial response in acute myeloid leukemia and stratifies outcomes in patients at standard risk without NPM1 mutations

    Sylvie Freeman, Naeem Khan, 20 May 2018, In: Journal of Clinical Oncology . 36, 15, p. 1486-1497 12 p.

    Research output: Contribution to journal › Article › peer-review

  20. Published

    Dasatinib in pediatric patients with chronic myeloid leukemia in chronic phase: results from a phase II trial

    Pamela Kearns, 1 May 2018, In: Journal of Clinical Oncology . 36, 13, p. 1330-1338 9 p.

    Research output: Contribution to journal › Article › peer-review

  21. Published

    Tumor PIK3CA genotype and prognosis in early-stage breast cancer: A pooled analysis of individual patient data

    & 12 others, , Daniel Rea, 1 Apr 2018, In: Journal of Clinical Oncology. 36, 10, p. 981-990 10 p.

    Research output: Contribution to journal › Article › peer-review

  22. Published

    Results of POUT: A phase III randomised trial of perioperative chemotherapy versus surveillance in upper tract urothelial cancer (UTUC)

    9 Feb 2018, In: Journal of Clinical Oncology . 36, Suppl 6S, Abstract 407.

    Research output: Contribution to journal › Abstract › peer-review

  23. 2017
  24. Published

    Improving outcomes in high-risk Myelodysplasia: Festina Lente

    Charles Craddock, 26 May 2017, In: Journal of Clinical Oncology . p. JCO2017730812

    Research output: Contribution to journal › Editorial › peer-review

Previous 1 2 3 4 5 6 Next